Anti-Human CD279 Recombinant Antibody(Camrelizumab)

Name: Anti-Human CD279 Recombinant Antibody(Camrelizumab)
Brand: KMD Bioscience
SKU: YR1436

YR1436

科研级 Camrelizumab ( 坎利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab

DATASHEET MSDS

Product Description

Alias	科研级 Camrelizumab ( 坎利珠单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab
Catalog Number	YR1436
Molecular Name	Camrelizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitionitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials.
CAS Number	1798286-48-2
Application	ELISA, IHC, IF, IP, FCM, Block
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD279[Homo sapiens]

Login